GENOTROPIN

16IU(5,3MG) INJ PSO LQF 5+5X1ML

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 29.05.2020
Interruption of marketing 02.04.2020 Lék nahraditelný přípravky ze stejné ATC skupiny (H01AC01: SOMATROPIN) - nutné posouzení lékaře Manufacturing reasons 30.06.2020

All reports are available in the Overview.

Back to list